BSE filing, NSE: ESAFSFB. Summary written from the filing by ALFA Finder's alert engine.
ESAF Small Finance Bank Ltd: key numbers
- Share price
- ₹42.94
- Market cap
- ₹2,216 Cr
- Revenue (annual)
- ₹3,537 Cr
- Net profit (annual)
- ₹-166.4 Cr
- P/E (TTM)
- 8.2×Sector 19.1×
- Promoter holding
- 63.23%-0.02% QoQ
- FII holding
- 0.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ESAF Small Finance Bank Ltd
All →ESAF Small Finance Bank Results Update
ESAF Small Finance Bank reported Q2 FY27 PAT of ₹160 Crore, with NNPA improving to 0.3%. Gross advances grew 25% YoY to ₹23,934 Crore.
ESAF Small Finance Bank Investor Presentation: Key Takeaways
Q2 FY27 PAT ₹160 Cr vs ₹116 Cr loss YoY; NII ₹643 Cr (+73% YoY). GNPA 2.8%, NIM 8.2%, CRAR 24.1%, cost-to-income 57.7%.
ESAF Small Finance Bank Q2 FY27 Results: Turns Profitable, Net Profit ₹160.2 Cr
ESAF Small Finance Bank Ltd reported revenue from operations of ₹1,175 Cr (+43.3% YoY) and net profit of ₹160.2 Cr for Q2 FY27.
- Key figure
- Net profit ₹160.2 Cr
ESAF Small Finance Bank Other Announcement
ESAF Small Finance Bank filed its quarterly shareholding pattern for September 2026. Promoters hold about 63% of shares, with voting rights capped at 26%.
ESAF Small Finance Bank Employee Stock Options
ESAF Small Finance Bank allotted 42,210 shares to employees on ESOP exercise. Total issued equity rises to 51,61,62,511 shares.
ESAF Small Finance Bank Business Update
ESAF Small Finance Bank completed its migration to the Oracle FLEXCUBE core banking system on 26 October 2026. Banking services have been restored to customers.
Other financial results announcements
All →Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +92.9% YoY
STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows
STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹16.1 Cr
RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY
RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.2 Cr · -23.6% YoY
Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY
Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · +51.1% YoY
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY
Bandaram Pharma Packtech Q2 FY27 Results: Net Profit ₹0.2 Cr, Up 100.0% YoY
Bandaram Pharma Packtech reported audited standalone and consolidated results for the quarter and half-year ended 30.09.2026. Consolidated revenue from operations for the half-year was Rs 4,540.28 lakhs.
- Key figure
- Net profit ₹0.2 Cr · +100.0% YoY